Expression of Fas-ligand in first trimester and term human placental villi

被引:57
作者
Hammer, A [1 ]
Dohr, G [1 ]
机构
[1] Karl Franzens Univ Graz, Inst Histol & Embryol, A-8010 Graz, Austria
关键词
apoptosis; Fas-ligand; human; immunohistochemistry; placenta; pregnancy; trophoblast cells;
D O I
10.1016/S0165-0378(99)00059-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The expression of Fas-ligand (FasL) on trophoblast cells is thought to play a role in immune regulation during human pregnancy. However, there are some discrepancies in the published data concerning the cell types expressing Fast in the placental villi. Therefore, we examined the expression of Fast on cryosections of first trimester and term placental tissue with three different anti-sera against Fast, which are in common use. By immunohistochemistry, all three anti-sera principally gave the same staining result. In the first trimester of pregnancy, villous cytotrophoblast cells underlying the syncytium, as well as all extravillous trophoblast cells of cell columns and cell islands, gave a clear, mainly membrane-located staining, whereas the syncytiotrophoblast, which forms the borderline to the maternal blood flow, only gave a spot-like reaction in distinct areas. The same result was obtained with term placental villi; however, in this tissue, the staining of the villous cytotrophoblast cells was less pronounced. From our results, we suggest that in placental villi, an important role of Fast in immune regulation is not very conclusive because this molecule is mainly expressed on trophoblast with no access to maternal blood or tissue. This is in contrast to the uterine part of the placenta, where Fast expressing trophoblast cells are in close contact with apoptotic maternal leukocytes. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:83 / 90
页数:8
相关论文
共 19 条
[1]   Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells [J].
Bamberger, AM ;
Schulte, HM ;
Thuneke, I ;
Erdmann, I ;
Bamberger, CM ;
Asa, SL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (09) :3173-3175
[2]  
Beer A.E., 1976, IMMUNOBIOLOGY MAMMAL
[3]   A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION [J].
BELLGRAU, D ;
GOLD, D ;
SELAWRY, H ;
MOORE, J ;
FRANZUSOFF, A ;
DUKE, RC .
NATURE, 1995, 377 (6550) :630-632
[4]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain [J].
Dowling, P ;
Shang, GF ;
Raval, S ;
Menonna, J ;
Cook, S ;
Husar, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1513-1518
[5]   A vision of cell death: Insights into immune privilege [J].
Ferguson, TA ;
Griffith, TS .
IMMUNOLOGICAL REVIEWS, 1997, 156 :167-184
[6]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[7]  
Hammer A, 1999, AM J REPROD IMMUNOL, V41, P41
[8]  
Hammer A, 1999, AM J REPROD IMMUNOL, V42, P88
[9]  
Hunt JS, 1997, J IMMUNOL, V158, P4122
[10]   Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta [J].
Huppertz, B ;
Frank, HG ;
Kingdom, JCP ;
Reister, F ;
Kaufmann, P .
HISTOCHEMISTRY AND CELL BIOLOGY, 1998, 110 (05) :495-508